---
title: "Aktis Oncology director Ken Herrmann disposes of common shares worth $119,256.78"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293400552.md"
description: "Aktis Oncology director Ken Herrmann sold 4,856 common shares on July 20, 2026, at $24.56 per share, totaling $119,256.78. He previously acquired these shares via option exercises priced at $0.08 and $1.91. Following the sale, his directly held stock position dropped to zero, leaving him with 18,364 outstanding options."
datetime: "2026-07-22T00:51:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293400552.md)
  - [en](https://longbridge.com/en/news/293400552.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293400552.md)
generator: "portal-rs"
---

# Aktis Oncology director Ken Herrmann disposes of common shares worth $119,256.78

-   Aktis Oncology director Ken Herrmann sold 4,856 shares on July 20, 2026 at USD 24.56 per share. \* He acquired the same 4,856 shares via option exercises priced at USD 0.08 and USD 1.91. \* His directly held common stock position fell to zero following the transactions. \* He reported 18,364 stock options remaining outstanding after the exercises. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aktis Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-310991), on July 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [AKTS.US](https://longbridge.com/en/quote/AKTS.US.md)

## Related News & Research

- [Aktis Oncology director Ken Herrmann disposes of 3,065 common shares worth $77,279.54](https://longbridge.com/en/news/293257302.md)
- [Aktis Oncology (NASDAQ:AKTS) Posts Earnings Results, Meets Expectations](https://longbridge.com/en/news/295844401.md)
- [ReNew Energy Global warrants set to be delisted after expiration](https://longbridge.com/en/news/296360098.md)
- [Better.com founder Vishal Garg seeks to oust five directors via written-consent campaign](https://longbridge.com/en/news/296401490.md)
- [Dogness issues 3,050,000 Class A shares after cash warrant exercise](https://longbridge.com/en/news/296088837.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**